Blueprint Medicines Corp (BPMC) Insider Trading

Total insider buys:
  • $348,278.00
Total insider sells:
  • $152,874,979.57
Most recent insider trade:
  • March 28, 2024
Most active insider trader:
  • Jeffrey W Albers
Trader NameDateTitleAmountPriceTypeTotal Value
July 15, 2019Insider830$94.98Sell$78,833.40
July 8, 2019Insider10,000$93.88Sell$938,800.00
June 27, 2019Director21,818$92.01Sell$2,007,474.18
June 20, 2019Director11,818$95.15Sell$1,124,482.70
June 17, 2019Director1,136$98.50Sell$111,896.00
June 17, 2019COO11,952$96.46Sell$1,152,889.92
June 17, 2019CEO5,000$99.06Sell$495,300.00
June 17, 2019Insider1,405$98.22Sell$137,999.10
June 13, 2019Insider2,733$88.04Sell$240,613.32
June 12, 2019Director25,000$84.77Sell$2,119,250.00
June 12, 2019CEO20,000$84.75Sell$1,695,000.00
March 15, 2019CEO20,000$86.39Sell$1,727,800.00
March 15, 2019Insider415$85.55Sell$35,503.25
March 4, 2019Insider2,300$84.66Sell$194,718.00
March 1, 2019COO21,644$85.05Sell$1,840,822.20
Nov. 5, 2018CEO20,000$63.49Sell$1,269,800.00
Sept. 17, 2018Insider2,300$70.47Sell$162,081.00
Aug. 6, 2018CEO20,000$70.59Sell$1,411,800.00
May 7, 2018CEO20,000$78.90Sell$1,578,000.00
March 19, 2018Director5,492$100.09Sell$549,694.28
March 15, 2018Insider2,300$100.07Sell$230,161.00
March 2, 2018CEO20,000$92.57Sell$1,851,400.00
Feb. 28, 2018Director25,000$87.89Sell$2,197,250.00
Feb. 14, 2018Director12,500$80.42Sell$1,005,250.00
Feb. 12, 2018Director17,500$74.84Sell$1,309,700.00
Feb. 12, 2018Insider6,775$74.93Sell$507,650.75
Nov. 21, 2017Insider18,334$65.45Sell$1,199,960.30
Nov. 15, 2017Director5,000$63.38Sell$316,900.00
Nov. 6, 2017CEO30,000$70.31Sell$2,109,300.00
Nov. 6, 2017Insider5,000$70.40Sell$352,000.00
Oct. 5, 2017Insider5,449$66.44Sell$362,031.56
Sept. 18, 2017Insider6,356$60.03Sell$381,550.68
Sept. 18, 2017Director2,500$60.00Sell$150,000.00
Aug. 9, 2017Insider5,000$48.60Sell$243,000.00
Aug. 8, 2017CEO30,000$49.62Sell$1,488,600.00
Aug. 7, 2017CEO20,000$49.08Sell$981,600.00
July 5, 2017Director7,500$55.06Sell$412,950.00
July 5, 2017Insider7,265$54.66Sell$397,104.90
June 28, 2017Director32,500$50.28Sell$1,634,100.00
June 28, 2017CEO20,000$50.47Sell$1,009,400.00
June 28, 2017Insider6,357$50.00Sell$317,850.00
March 16, 2017Major Shareholder30,000$40.88Sell$1,226,400.00
Feb. 7, 2017Major Shareholder1,000,000$35.28Sell$35,280,000.00
Dec. 19, 2016Major Shareholder106,489$28.19Sell$3,001,924.91
Dec. 1, 2016Director200$30.02Sell$6,004.00
Oct. 13, 2016Director21,800$30.02Sell$654,436.00
Aug. 8, 2016CEO17,000$22.86Sell$388,620.00
June 3, 2016CEO17,000$20.03Sell$340,510.00
April 13, 2016Insider15,872$20.01Sell$317,598.72
April 12, 2016Insider18,853$20.14Sell$379,699.42
  • Insiders are both buying and selling Blueprint Medicines Corp stock.

  • The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Daniel Lynch, Christopher K Murray, Marion Dorsch, George Demetri, Nicholas Lydon, Anthony L Boral, Tracey L Mccain, Fmr Llc, L. Becker Hewes, Christina Rossi, Christoph Lengauer, Michael Landsittel, Mark Alan Goldberg, Fouad Namouni, Debra Durso-Bumpus, Charles A Rowland Jr, Percy H Carter, Kevin P. Starr, Rock Ventures Ii L.P. Third, Lonnel Coats, Alexis Borisy, and Mark J Levin

  • The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 38 trades.

  • Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.

  • Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.

  • The most recent insider trade for Blueprint Medicines Corp was on March 28, 2024.

  • The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.

  • The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.